Showing results (221-230 of 831) with videos related to

Sort By:
Pageof 84
Blood|January 9, 2007
Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemiaElias Jabbour, Susan O'Brien, Hagop Kantarjian, et al.
Blood|November 28, 2007
Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapySusan O'Brien, Farhad Ravandi, Todd Riehl, et al.
Blood|July 29, 2009
Role of leukemia cell invadosome in extramedullary infiltrationMichael Stefanidakis, Katja Karjalainen, Diana E Jaalouk, et al.
Oncotarget|November 19, 2016
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemiaNeil E Kay, Paolo Strati, Betsy R LaPlant, et al.
Leukemia & Lymphoma|December 11, 2007
Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic featuresDeborah A Bowen, Timothy G Call, Greg D Jenkins, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 26, 2018
Improvement in Parameters of Hematologic and Immunologic Function and Patient Well-being in the Phase III RESONATE Study of Ibrutinib Versus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaJacqueline C Barrientos, Susan O'Brien, Jennifer R Brown, et al.
Haematologica|March 2, 2011
Outcome of patients with chronic myeloid leukemia with multiple ABL1 kinase domain mutations receiving tyrosine kinase inhibitor therapyAlfonso Quintás-Cardama, Hagop Kantarjian, Susan O'Brien, et al.
Blood|April 12, 2008
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapyElias Jabbour, Hagop Kantarjian, Dan Jones, et al.
European Journal of Haematology|April 22, 2023
Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice changeBenjamin J Lee, Piyanuch Kongtim, Jean Doh, et al.
Cancer|May 13, 2004
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemiaYupo Ma, Adnan Mansour, B Nebiyou Bekele, et al.
Pageof 84